Yükleniyor…
Buradaki her şirket aynı beş büyüme ve nakit üretimi kontrolünden geçirildi. Bu, sektörü bugün bildirdiği hâliyle anlatır — hangisinin alınacağını değil.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | C | $50,4B | $43,21 | 100,49 | $17,2B | %2,9 |
| HLN | Haleon plc | B+ | $40,7B | $9,09 | 18,33 | $14,8B | %15,1 |
| ZTS | Zoetis Inc. | C+ | $33,5B | $82,57 | 13,92 | $9,5B | %26,4 |
| TAK | Takeda Pharmaceutical Company Limited | A | $33,5B | $20,86 | 48,79 | $29,8B | %0,9 |
| UTHR | United Therapeutics Corporation | C+ | $25,4B | $595,58 | 22,48 | $3,2B | %38,6 |
| VTRS | VIATRIS INC. | D | $24,1B | $21,06 | — | $14,7B | -%23,9 |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | A+ | $17,6B | $174,35 | 25,87 | $3,7B | %19,0 |
| ELAN | Elanco Animal Health Incorporated | A | $13,2B | $26,48 | — | $5,1B | -%2,9 |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B | $12,4B | $14,83 | 20,77 | $3,5B | %4,4 |
| KNSA | Kiniksa Pharmaceuticals International, plc | A+ | $8,1B | $95,80 | 73,13 | $946M | %11,6 |
| ALKS | Alkermes plc. | C | $8B | $47,88 | — | $1,8B | -%0,0 |
| AMRX | Amneal Pharmaceuticals, Inc. | C | $7,6B | $21,72 | 51,71 | $3,2B | %4,2 |
| LNTH | LANTHEUS HOLDINGS, INC. | B+ | $6,6B | $101,58 | 25,08 | $1,6B | %17,3 |
| LQDA | LIQUIDIA CORPORATION | A | $5B | $55,19 | — | $621,9M | -%15,1 |
| HIMS | HIMS & HERS HEALTH, INC. | C- | $4,9B | $20,81 | — | $2,9B | -%6,7 |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | $4,1B | $31,78 | — | $0,00 | — |
| BHC | Bausch Health Companies Inc. | A | $3,1B | $8,35 | — | $11,1B | -%7,6 |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | $3B | $16,51 | — | $368,3M | -%1,8 |
| RGC | REGENCELL BIOSCIENCE HOLDINGS LIMITED | notsuz | $2,7B | $5,45 | — | — | — |
| HCM | HutchMED (China) LIMITED | D | $2,6B | $15,04 | — | $549,1M | %3,3 |
| PRGO | Perrigo Company plc | F- | $2,3B | $16,56 | — | $4,1B | -%43,3 |
| TRLV | TRULIEVE CANNABIS CORP. | F | $2,3B | $11,24 | — | $1,1B | -%41,3 |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | $2,1B | $44,17 | 13,63 | $1,2B | %13,3 |
| ETON | ETON PHARMACEUTICALS, INC. | A+ | $2B | $68,42 | — | $141,1M | %35,3 |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | B | $2B | $7,65 | — | $961,5M | -%37,4 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | B | $1,7B | $29,42 | — | $865,1M | -%5,1 |
| ANIP | ANI PHARMACEUTICALS, INC | B+ | $1,5B | $71,23 | 14,22 | $1B | %11,2 |
| ALVO | ALVOTECH | B | $1,5B | $4,93 | 49,25 | $586,3M | %4,8 |
| PCRX | PACIRA BIOSCIENCES, INC. | B | $1,5B | $36,47 | 39,22 | $743,3M | %5,1 |
| PAHC | Phibro Animal Health Corporation | B | $1,4B | $35,13 | 14,00 | $1,5B | %6,7 |
| CRON | CRONOS GROUP INC. | A | $1,3B | $3,46 | 20,32 | $206,2M | %28,0 |
| AMPH | Amphastar Pharmaceuticals, Inc. | B+ | $1,2B | $28,61 | 13,06 | $745,8M | %13,3 |
| HROW | Harrow, Inc. | D- | $1,1B | $29,30 | — | $303,3M | -%9,4 |
| BGM | BGM Group Ltd | F- | $985,4M | $8,70 | — | $47,9M | -%44,2 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | C+ | $804,6M | $4,86 | 5,40 | $400,3M | %37,4 |
| COLL | Collegium Pharmaceutical, Inc. | B | $770,5M | $24,80 | 24,80 | $815,2M | %4,7 |
| TKNO | ALPHA TEKNOVA, INC. | B- | $541,6M | $8,61 | — | $46M | -%34,8 |
| EOLS | EVOLUS, INC. | B | $492,1M | $7,44 | — | $325,5M | -%9,6 |
| KMDA | KAMADA LTD | C+ | $469,6M | $8,14 | 18,93 | $196,9M | %13,6 |
| AQST | Aquestive Therapeutics, Inc. | D | $449,3M | $3,58 | — | $48,8M | -%162,3 |
| TLRY | Tilray Brands, Inc. | C- | $385M | $2,61 | — | $963,1M | -%17,1 |
| EBS | EMERGENT BIOSOLUTIONS INC. | D | $310,3M | $6,04 | — | $649,1M | -%40,2 |
| EVO | Evotec SE | F- | $304,9M | $1,72 | — | $836,2M | -%26,0 |
| ACB | AURORA CANNABIS INC | D- | $280,9M | $5,05 | 176,32 | $225,8M | -%29,9 |
| BIOA | BIOAGE LABS, INC. | F- | $268,9M | $5,85 | — | $8,6M | -%1.253,6 |
| CGC | Canopy Growth Corporation | C- | $256,3M | $0,61 | — | $219,2M | -%87,0 |
| LFCR | LIFECORE BIOMEDICAL, INC. | F | $242,4M | $6,40 | — | $128,9M | -%30,0 |
| SIGA | Siga Technologies INC | F | $225,6M | $3,14 | — | $52,4M | %1,3 |
| INCR | INTERCURE LTD. | C- | $219,8M | $4,02 | — | $86,4M | -%13,2 |
| ADCT | ADC Therapeutics SA | C | $203,6M | $1,60 | — | $84,9M | -%95,7 |
| ANIK | Anika Therapeutics, Inc. | B- | $186,3M | $13,91 | — | $123,4M | -%1,4 |
| GLAS | Glass House Brands Inc. | F- | $165,5M | $1,90 | — | $152,9M | -%33,7 |
| AKBA | AKEBIA THERAPEUTICS, INC. | D | $158M | $0,57 | — | $197,2M | -%22,6 |
| ORGO | ORGANOGENESIS HOLDINGS INC. | F- | $136,3M | $1,05 | — | $352M | -%38,4 |
| DERM | Journey Medical Corp | C- | $125,7M | $4,46 | — | $68,2M | -%9,0 |
| CRDL | Cardiol Therapeutics Inc. | notsuz | $100,8M | $1,01 | — | — | — |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | $94,8M | $6,33 | — | $39,9M | -%27,4 |
| INM | INMED PHARMACEUTICALS INC. | F- | $85,5M | $15,56 | — | $4,5M | -%292,1 |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | $81,3M | $0,85 | — | $185,5M | -%9,6 |
| ZYBT | Zhengye Biotechnology Holding Limited | D | $72,3M | $1,53 | — | $17,5M | -%60,0 |
| CTOR | Citius Oncology, Inc. | notsuz | $51,7M | $0,56 | — | — | — |
| SCYX | SCYNEXIS INC | F- | $34,1M | $3,43 | — | $18,9M | -%53,5 |
| RMTI | ROCKWELL MEDICAL, INC. | B- | $28,7M | $7,13 | — | $72,6M | -%7,8 |
| CPHI | CHINA PHARMA HOLDINGS, INC. | D- | $22,7M | $0,53 | — | $3,9M | -%114,3 |
| TXMD | TherapeuticsMD, Inc. | F- | $21,4M | $1,85 | — | $3,3M | -%6,6 |
| AYTU | AYTU BIOPHARMA, INC. | C | $19,7M | $1,82 | — | $57,6M | -%24,8 |
| RDHL | REDHILL BIOPHARMA LTD. | F | $17,9M | $0,40 | — | -$3,7M | -%72,5 |
| TLPH | TALPHERA, INC. | D- | $15M | $1,05 | — | $1K | -%1.465.800,0 |
| BFRI | Biofrontera Inc. | B- | $13,9M | $0,93 | — | $46,2M | -%13,8 |
| SBFM | Sunshine Biopharma Inc. | D- | $10,7M | $2,76 | — | $35,3M | -%16,5 |
| CABR | Caring Brands, Inc. | F- | $9,2M | $0,88 | — | $4,2K | -%183.255,2 |
| IMCC | IM Cannabis Corp. | D | $7,2M | $0,56 | — | $32,8M | -%40,1 |
| SNOA | SONOMA PHARMACEUTICALS, INC. | C- | $6,2M | $1,23 | — | $23,5M | -%7,6 |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | notsuz | $5,4M | $5,32 | — | — | — |
| GELS | Gelteq Limited | D- | $4M | $0,43 | — | $116,4K | -%4.011,9 |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | notsuz | $3,4M | $2,28 | — | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | $2,8M | $2,89 | — | $1,1M | -%545,2 |
| YCBD | cbdMD, Inc. | D- | $1,6M | $0,39 | — | $20,9M | -%13,8 |
| IXHL | Incannex Healthcare Inc. | F- | $993,5K | $1,98 | — | $0,00 | — |
| UPC | Universe Pharmaceuticals INC | D- | $907K | $1,61 | — | $17,9B | -%20,6 |
| PRFX | PRF Technologies Ltd. | B- | $629,5K | $0,76 | — | $17K | -%29.541,2 |
| AKAN | Akanda Corp. | F | $50,4K | $0,73 | — | $258,1K | -%19.775,5 |
| INDV | Indivior Pharmaceuticals, Inc. | A | — | $28,15 | — | $1,4B | %32,8 |
| OPTH | Optimi Health Corp. | notsuz | — | $2,19 | — | — | — |
Temeller SEC belgelerinden, fiyatlar son piyasa verisi taramasından. İstediğiniz sütuna göre sıralayın; rakamı olmayan şirketler her iki yönde de sona düşer.
Piyasa değerine göre büyükten küçüğe sıralı; yeniden sıralamak için herhangi bir sütuna tıklayın. Rakamı olmayan şirketler her iki yönde de sona düşer, çünkü eksik bir F/K ucuzluk değil zarar demektir. Buradaki hiçbir şey bir öneri değildir.